To thoroughly evaluate pharmacodynamic effect of PLK1 inhibition in vivo, tumors from the PSN-1 xenograft tumor model in M-NSG mice were collected at 2 and 6 hours following a single oral dose of the compounds at varying concentrations (60, 30, and 15 mg/kg). This evidence concerns the gene PLK1 and neoplasm.